Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Corvus Pharmaceuticals (CRVS) Other Gross PP&E Adjustments (2022 - 2025)

Historic Other Gross PP&E Adjustments for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $1.7 million.

  • Corvus Pharmaceuticals' Other Gross PP&E Adjustments fell 5972.32% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 5972.32%. This contributed to the annual value of $3.3 million for FY2024, which is 25888.52% up from last year.
  • Corvus Pharmaceuticals' Other Gross PP&E Adjustments amounted to $1.7 million in Q3 2025, which was down 5972.32% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Corvus Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $4.2 million in Q3 2024 and a low of -$2.8 million during Q4 2022
  • Over the past 4 years, Corvus Pharmaceuticals' median Other Gross PP&E Adjustments value was $2.4 million (recorded in 2022), while the average stood at $1.9 million.
  • As far as peak fluctuations go, Corvus Pharmaceuticals' Other Gross PP&E Adjustments soared by 25888.52% in 2024, and later tumbled by 6628.8% in 2025.
  • Quarter analysis of 4 years shows Corvus Pharmaceuticals' Other Gross PP&E Adjustments stood at -$2.8 million in 2022, then increased by 25.17% to -$2.1 million in 2023, then soared by 258.89% to $3.3 million in 2024, then crashed by 49.39% to $1.7 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $1.7 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.2 million for Q1 2025.